Plasma levels of vascular endothelial growth factor during and after radiotherapy in combination with celecoxib in patients with advanced head and neck cancer. [electronic resource]
Producer: 20111027Description: 763-7 p. digitalISSN:- 1879-0593
- Adult
- Aged
- Carcinoma, Squamous Cell -- drug therapy
- Celecoxib
- Clinical Trials, Phase II as Topic
- Combined Modality Therapy -- adverse effects
- Cyclooxygenase 2 -- metabolism
- Cyclooxygenase 2 Inhibitors -- administration & dosage
- Female
- Head and Neck Neoplasms -- drug therapy
- Humans
- Male
- Middle Aged
- Pyrazoles -- administration & dosage
- Sulfonamides -- administration & dosage
- Vascular Endothelial Growth Factor A -- blood
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.